Well that would be a potential game changer, makes sales/conversions of users of other devices a lot easier and eases fears about reimbursement being ceased. Good timing as well for the new marketing staff, if they can't sell quicker device to use now with long term outcome data and higher reimbursement rates now they should find a new profession.
30% extra reimbursement goes straight to the bottom line for profitability of performing a procedure and ease of using device increases the profitability as well as you can do more procedures per session, so the economics of itrack vs itrack advance are hugely improved for operators.
Well that would be a potential game changer, makes...
-
- There are more pages in this discussion • 493 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.10M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 21.0¢ | $45.70K | 217.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2722 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 57356 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |